Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
123.8 USD | -4.64% |
|
-5.29% | +13.56% |
28/06 | Merck: positive opinion for Winrevair in Europe | CF |
28/06 | Merck Gets CHMP Backing of Winrevair in Pulmonary Arterial Hypertension | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.56% | 31TCr | |
+55.32% | 82TCr | |
-6.75% | 35TCr | |
+10.68% | 30TCr | |
+16.57% | 24TCr | |
+2.04% | 22TCr | |
+13.31% | 22TCr | |
+8.48% | 17TCr | |
-2.81% | 16TCr | |
+0.20% | 12TCr |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Wells Fargo Adjusts Price Target on Merck & Company to $140 From $135